Newbury Pharmaceuticals develops and markets specialty prescription drugs in Scandinavia, focusing on therapeutic areas like oncology, rare diseases, and neurology. The company provides accessible treatment solutions by building a pipeline of proprietary and licensed products, serving as a local partner for patients and healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Patients in Scandinavia often face limited access to specialized prescription drugs, particularly in therapeutic areas like oncology, rare diseases, and neurology. This gap in treatment availability can hinder timely and effective patient care.
Solution
Newbury Pharmaceuticals operates as a hybrid pharmaceutical company focused on developing and marketing specialty prescription drugs within the Scandinavian region. The company aims to provide accessible treatment solutions by building a pipeline of proprietary and licensed products. By focusing on key therapeutic areas, Newbury Pharmaceuticals serves as a local alternative partner to larger multinational corporations, contributing to the overall healthcare system and patient well-being.
Target Audience
The primary target audience includes healthcare providers, hospital networks, and patients in Scandinavia requiring access to specialized prescription medications.
Features
- Development and marketing of branded specialty prescription drugs.
- Focus on therapeutic areas including oncology, rare diseases, and neurology.
- Securing marketing authorizations for generic and branded products across Scandinavia.
- Expanding portfolio through strategic partnerships and product acquisitions.
- Commercialization of niche antibiotics and hospital-use pharmaceuticals.
- Regulatory filings and approvals for various drug formulations and delivery methods.